VÝSLEDKY VYHLEDÁVÁNÍ: (10000 výsledků)
superficial and interfascial cervical
Články časopisu
© 2016 Hsieh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The electronic version of this article is the complete one and can be found online at: http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0156185
The electronic version of this article is the complete one and can be found online at: http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0156185
Články časopisu
© 2016 Himpe et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The electronic version of this article is the complete one and can be found online at: http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0157604
The electronic version of this article is the complete one and can be found online at: http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0157604
Články časopisu
© 2016 Nillius et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The electronic version of this article is the complete one and can be found online at: http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0153030
The electronic version of this article is the complete one and can be found online at: http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0153030
Kalendář kongresů A New Treatment in Alopecia Areata
Speakers: Dr. Sergio Vañó Galván (MD, PhD) and Prof. Bianca Maria Piraccini (MD, PhD)
- Clinical presentation and burden of Alopecia Areata (AA)
- Current therapies for AA and their limitations
- Pathophysiology of AA and rationale for targeting JAK1 and JAK2
- Olumiant efficacy and safety data in patients with severe AA
- How to initiate and monitor patients on Olumiant